{"chunk_type":"transcript_chunk","text":"# LM_obs1\n**0:00 ~ 0:30 Dictation (Verbatim Verification)**\n\"Welcome back to the deep dive. Today we are heading straight to the OB floors. And listen, I know exactly what you're thinking. Oh yeah. You're thinking about the high drama moments, the emergency C-sections, the shoulder dystocias, maybe some, you know, rare tropical disease that shows up in a question bank. The zebras. The zebras, but let me set a different scene. You're on the wards, it's 2 a.m., and you're just staring at a patient's labs or fetal monitor. Your ability to crush Step 2...\"\n---\n# ğŸ¤° OB Floor Survival Guide: Pregnancy Physiology & Common Scenarios\n## 1. Introduction: Understanding the Baseline\nê°•ì˜ëŠ” Step 2ì—ì„œ ì‚´ì•„ë‚¨ìœ¼ë ¤ë©´ í™”ë ¤í•œ \"zebra\" ì¼€ì´ìŠ¤ë³´ë‹¤ëŠ” **Normal Physiology**ë¥¼ ì™„ë²½í•˜ê²Œ ì´í•´í•´ì•¼ í•œë‹¤ëŠ” ì ì„ ê°•ì¡°í•˜ë©´ì„œ ì‹œì‘í•©ë‹ˆë‹¤. ì„ì‹  ì¤‘ ìƒë¦¬ëŠ” 9ê°œì›” ë™ì•ˆ ëª¨ë“  ì¥ê¸° ì‹œìŠ¤í…œì— ê°€í•´ì§€ëŠ” **Stress Test**ì™€ ê°™ìŠµë‹ˆë‹¤. \"Normal\"ì´ ë¬´ì—‡ì¸ì§€ ëª¨ë¥´ë©´ ë³‘ì ì¸ ìƒíƒœë¥¼ êµ¬ë¶„í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.\n- **Pregnancy Physiology**: 9-month stress test for every organ system.\n- **The Trap**: ì„ì‹  ì¤‘ì—ëŠ” physiologyê°€ ê·¹ì ìœ¼ë¡œ ë³€í•˜ê¸° ë•Œë¬¸ì—, non-pregnant patient ê¸°ì¤€ìœ¼ë¡œëŠ” \"emergency\"ì¸ ìˆ˜ì¹˜ê°€ ì„ì‹ ë¶€ì—ê²ŒëŠ” ì •ìƒì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n## 2. Renal Physiology: The Filtration System\nê°€ì¥ ë¨¼ì € ì‹ ì¥(Kidneys)ì˜ ë³€í™”ë¥¼ ë‹¤ë£¹ë‹ˆë‹¤.\n### ğŸŒŠ Hydronephrosis & Dilated Ureters\n- **Clinical Scenario**: Mid-second trimester ì‚°ëª¨ê°€ **Right flank fullness** ë˜ëŠ” mild painì„ í˜¸ì†Œí•¨. Fever (-), White count (-), Stones (-) ì¸ë°, Ultrasoundì—ì„œ **Mild Hydronephrosis**ê°€ ë³´ì„.\n- **Reaction**: í•™ìƒë“¤ì€ Obstructionì„ ì˜ì‹¬í•˜ê³  Urologyë¥¼ ë¶€ë¥´ë ¤ê³  í•˜ì§€ë§Œ, ì´ëŠ” **Physiological Trap**ì…ë‹ˆë‹¤.\n- **Mechanism**:\n    1. **Hormonal**: **Progesterone**ì´ smooth muscle relaxantë¡œ ì‘ìš©í•˜ì—¬ Ureterë¥¼ í™•ì¥ì‹œí‚¤ê³  ëŠë¦¬ê²Œ ë§Œë“­ë‹ˆë‹¤ (baggy and sluggish).\n    2. **Mechanical**: ì»¤ì§„ **Uterus** (íŠ¹íˆ Dextrorotation ê²½í–¥ì´ ìˆìŒ)ê°€ **Right Ureter**ë¥¼ ë¬¼ë¦¬ì ìœ¼ë¡œ ëˆ„ë¦…ë‹ˆë‹¤.\n- **Conclusion**: Infection ì§•í›„ê°€ ì—†ëŠ” **Mild Right-sided Hydronephrosis**ëŠ” ì„ì‹  ì¤‘ **Normal**ì…ë‹ˆë‹¤.\n### ğŸ§ª Glomerular Filtration Rate (GFR) & Creatinine\n- **Hemodynamics**: ì„ì‹  ì¤‘ì—ëŠ” Blood volumeê³¼ Cardiac outputì´ ì—„ì²­ë‚˜ê²Œ ì¦ê°€í•©ë‹ˆë‹¤.\n- **Result**: Kidneysê°€ \"hammered with flow\" ìƒíƒœê°€ ë˜ì–´ **GFRì´ 50% ì¦ê°€**í•©ë‹ˆë‹¤.\n- **Creatinine (Cr)**: GFRì´ ì¦ê°€í•˜ë¯€ë¡œ Crì€ í‰ì†Œë³´ë‹¤ ë” ë§ì´ ë°°ì„¤ë˜ì–´ ë–¨ì–´ì§‘ë‹ˆë‹¤.\n    - **Non-pregnant Normal**: Cr 1.0 ~ 1.1\n    - **Pregnant Normal**: Cr 0.4 ~ 0.8\n    - **ğŸš¨ RED FLAG**: ì„ì‹ ë¶€ì˜ Crì´ 1.0 ~ 1.1ì´ë¼ë©´, ì´ëŠ” ì¼ë°˜ì¸ì—ê²ŒëŠ” ì •ìƒì´ì§€ë§Œ ì„ì‹ ë¶€ì—ê²ŒëŠ” **Renal Insufficiency**ë¥¼ ì˜ë¯¸í•˜ëŠ” ë³‘ì ì¸ ìˆ˜ì¹˜ì…ë‹ˆë‹¤.\n| **Condition** | **Non-Pregnant Cr** | **Pregnant Cr** | **Status in Pregnancy** |\n| --- | --- | --- | --- |\n| Normal | 1.0 ~ 1.1 | 0.4 ~ 0.8 | **Physiologic** |\n| Renal Issue | > 1.2 | 1.0 ~ 1.1 | **Pathologic (Red Flag)** |\n## 3. Musculoskeletal Changes: The Back Pain Dilemma\nê°€ì¥ í”í•œ ë¶ˆë§Œ ì¤‘ í•˜ë‚˜ì¸ **Back Pain**ì— ëŒ€í•œ ì ‘ê·¼ë²•ì…ë‹ˆë‹¤.\n### ğŸ¦´ Lordosis & Mechanical Strain\n- **Clinical Scenario**: 30ì£¼ ì‚°ëª¨ê°€ í—ˆë¦¬ë¥¼ ì¡ê³  ë’¤ëš±ê±°ë¦¬ë©° ë“¤ì–´ì˜´(waddling). ê±·ê³  ë‚˜ë©´ ë‹¤ë¦¬ê°€ ì €ë¦¬ë‹¤ê³  í•˜ë©°, ë³¸ì¸ì€ **Herniated Disc**ë¼ê³  í™•ì‹ í•˜ê³  **MRI**ë¥¼ ìš”êµ¬í•¨.\n- **Physiology**:\n    1. **Center of Gravity Shift**: Uterusê°€ ì»¤ì§€ë©´ì„œ ë¬´ê²Œ ì¤‘ì‹¬ì´ ì•ìœ¼ë¡œ ì ë¦½ë‹ˆë‹¤. ë„˜ì–´ì§€ì§€ ì•Šìœ¼ë ¤ê³  ìƒì²´ë¥¼ ë’¤ë¡œ ì –íˆê²Œ ë˜ë©° **Lordosis (Swayback posture)**ê°€ ì‹¬í•´ì§‘ë‹ˆë‹¤.\n    2. **Hormonal**: **Progesterone**ê³¼ **Relaxin**ì´ ê´€ì ˆê³¼ ì¸ëŒ€ë¥¼ ëŠìŠ¨í•˜ê²Œ ë§Œë“­ë‹ˆë‹¤. (Sacroiliac joint, Pelvis ë“±)\n    3. **Muscle Weakness**: ë³µê·¼(Abdominal muscles)ì´ ëŠ˜ì–´ë‚˜ ì•½í•´ì§€ë©´ì„œ í—ˆë¦¬ë¥¼ ì§€ì§€í•´ì£¼ì§€ ëª»í•©ë‹ˆë‹¤.\n- **Key Question**: **MRIë¥¼ ì°ì–´ì•¼ í•˜ëŠ”ê°€?**\n    - **Answer**: **Absolutely NOT**. Typical painì—ëŠ” imagingì„ í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤. ì˜¤ì§ \"Red flags\" (progressive neuro deficits ë“±)ê°€ ìˆì„ ë•Œë§Œ ê³ ë ¤í•©ë‹ˆë‹¤.\n- **Management**: **Conservative Management** (Reassurance, Low-heeled shoes, Back support, Massage, Heating pads). \"Suck it up\"ì´ë¼ê³  ë§í•˜ëŠ” ëŒ€ì‹  ìƒë¦¬í•™ì  ì›ì¸ì„ ì„¤ëª…í•˜ê³  ì•ˆì‹¬ì‹œí‚¤ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.\n## 4. Trauma & Blood Compatibility: Mixing Issues","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-1"}
{"chunk_type":"transcript_chunk","text":"ì„ì‹  ì¤‘ Traumaë‚˜ ì¶œí˜ˆ ì´ë²¤íŠ¸ ì‹œ ë°œìƒí•  ìˆ˜ ìˆëŠ” **Rh Incompatibility** ë¬¸ì œì…ë‹ˆë‹¤.\n### ğŸ©¸ Fetomaternal Hemorrhage\n- **Scenario**: **Rh-negative** ì‚°ëª¨ê°€ Trauma(ì°¨ ì‚¬ê³ , ë‚™ìƒ ë“±)ë¥¼ ê²ªìŒ. Fetal bloodê°€ Maternal circulationìœ¼ë¡œ ë„˜ì–´ê°ˆ ìœ„í—˜ì´ ìˆìŒ.\n- **Risk**: ì—„ë§ˆê°€ Fetal RBCì— ëŒ€í•´ Antibodyë¥¼ í˜•ì„±(Sensitization)í•˜ë©´ ë‹¤ìŒ ì„ì‹  ë•Œ íƒœì•„ë¥¼ ê³µê²©í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **Action**: **RhoGAM (Anti-D Immune Globulin)**ì„ íˆ¬ì—¬í•´ì•¼ í•©ë‹ˆë‹¤. í•˜ì§€ë§Œ **ì–¼ë§ˆë‚˜(Dose)** ì¤˜ì•¼ í•˜ëŠ”ì§€ê°€ ë¬¸ì œì…ë‹ˆë‹¤.\n### ğŸ”¬ Kleihauer-Betke (KB) Test\n- **Concept**: Maternal bloodì™€ Fetal bloodë¥¼ êµ¬ë¶„í•˜ëŠ” í…ŒìŠ¤íŠ¸ì…ë‹ˆë‹¤.\n- **Mechanism (Acid Elution)**:\n    - **Adult Hemoglobin (HbA)**: Acidì— ë¶ˆì•ˆì •í•˜ì—¬ ì”»ê²¨ ë‚˜ê°‘ë‹ˆë‹¤ â†’ \"Ghost cells\" (empty).\n    - **Fetal Hemoglobin (HbF)**: ì‚°ì†Œë¥¼ ëºì–´ì˜¤ê¸° ìœ„í•´ êµ¬ì¡°ê°€ ë” íŠ¼íŠ¼í•˜ê³  Acidì— ì €í•­ì„±ì´ ê°•í•©ë‹ˆë‹¤ â†’ **Bright Pink Cells**ë¡œ ë‚¨ìŠµë‹ˆë‹¤.\n- **Calculation**: ë‚¨ì•„ìˆëŠ” Pink cells (Fetal cells)ì˜ ë¹„ìœ¨ì„ ì„¸ì–´ ì¶œí˜ˆëŸ‰(Hemorrhage volume)ì„ ê³„ì‚°í•˜ê³ , ê·¸ì— ë§ì¶° **RhoGAM dose**ë¥¼ ê²°ì •í•©ë‹ˆë‹¤.\n    - Standard doseëŠ” ì•½ 30mLì˜ fetal bloodë¥¼ ì»¤ë²„í•©ë‹ˆë‹¤. KB test ê²°ê³¼ ì¶œí˜ˆì´ ë” ë§ìœ¼ë©´ ìš©ëŸ‰ì„ ëŠ˜ë ¤ì•¼ í•©ë‹ˆë‹¤.\n## 5. Oxytocin & ADH: The Structural Twins\n**Labor induction** ì¤‘ ë°œìƒí•  ìˆ˜ ìˆëŠ” ì˜ì™¸ì˜ ë¶€ì‘ìš©ì…ë‹ˆë‹¤.\n### ğŸ’§ Water Intoxication (Hyponatremia)\n- **Scenario**: ì‚°ëª¨ê°€ **High-dose Oxytocin**ìœ¼ë¡œ ìœ ë„ ë¶„ë§Œ ì¤‘. ê°‘ìê¸° í˜¼ë€ìŠ¤ëŸ¬ì›Œí•˜ê±°ë‚˜(confusion), ì‹¬í•˜ë©´ ë°œì‘(seizure)ì„ ì¼ìœ¼í‚´.\n- **Mechanism**: **Oxytocin**ì€ ë‡Œí•˜ìˆ˜ì²´ í›„ì—½(Posterior Pituitary)ì—ì„œ ë¶„ë¹„ë˜ëŠ” **ADH (Vasopressin)**ì™€ êµ¬ì¡°ì ìœ¼ë¡œ ë§¤ìš° ë¹„ìŠ·í•©ë‹ˆë‹¤ (\"Evolutionary Cousins\").\n- **Result**: ê³ ìš©ëŸ‰ì˜ Oxytocinì€ ì‹ ì¥ì—ì„œ ADHì²˜ëŸ¼ ì‘ìš©í•˜ì—¬ **Water Retention**ì„ ìœ ë°œí•©ë‹ˆë‹¤. ì´ëŠ” **Severe Hyponatremia**ì™€ Water intoxicationìœ¼ë¡œ ì´ì–´ì ¸ Seizureë¥¼ ì¼ìœ¼í‚¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **Lesson**: Oxytocinì„ ì“¸ ë•ŒëŠ” Fluid statusì™€ Electrolyteë¥¼ ì£¼ì˜ ê¹Šê²Œ ë´ì•¼ í•©ë‹ˆë‹¤.\n## 6. Amniotic Fluid: The Fetal Environment\nì–‘ìˆ˜ëŸ‰ì˜ ì´ìƒì€ íƒœì•„ë‚˜ ì‚°ëª¨ì˜ ìƒíƒœë¥¼ ë°˜ì˜í•˜ëŠ” ê±°ìš¸ì…ë‹ˆë‹¤.\n### â¬†ï¸ Polyhydramnios (Too much fluid)\n- **Definition**: ì–‘ìˆ˜ê°€ ë„ˆë¬´ ë§ì€ ìƒíƒœ.\n- **Mechanisms**:\n    1. **Swallowing Issue**: íƒœì•„ê°€ ì–‘ìˆ˜ë¥¼ ì‚¼í‚¤ì§€ ëª»í•¨ (ì˜ˆ: Esophageal Atresia, Anencephaly).\n    2. **High Output**: íƒœì•„ê°€ ì†Œë³€ì„ ë„ˆë¬´ ë§ì´ ë´„ (ì˜ˆ: Maternal Diabetes â†’ Fetal Hyperglycemia â†’ Polyuria).\n### â¬‡ï¸ Oligohydramnios (Too little fluid)\n- **Definition**: ì–‘ìˆ˜ê°€ ë„ˆë¬´ ì ì€ ìƒíƒœ. ì–‘ìˆ˜ëŠ” ê³§ íƒœì•„ì˜ ì†Œë³€(Fetal Urine)ì…ë‹ˆë‹¤.\n- **Mechanisms**:\n    1. **Renal Agenesis**: ì‹ ì¥ì´ ì•ˆ ë§Œë“¤ì–´ì§ (Potter sequence).\n    2. **Obstruction**: ìš”ë„ê°€ ë§‰í˜ (Posterior Urethral Valves).\n    3. **Placental Insufficiency**: íƒœë°˜ ê¸°ëŠ¥ ì €í•˜ â†’ íƒœì•„ í˜ˆë¥˜ ê°ì†Œ â†’ ì†Œë³€ ìƒì„± ê°ì†Œ.\n- **Complication**: **Variable Decelerations**. ì–‘ìˆ˜ê°€ ì—†ìœ¼ë©´ ì™„ì¶© ì‘ìš©ì´ ì‚¬ë¼ì ¸ íƒ¯ì¤„(Umbilical cord)ì´ ìê¶ ìˆ˜ì¶• ì‹œë§ˆë‹¤ ëˆŒë¦¬ê²Œ ë©ë‹ˆë‹¤.\n---","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-21"}
{"chunk_type":"recap_summary","text":"# ğŸ”¥ Rapid Fire Recap: Must-Know High Yields\nStep 2 CK ì‹œí—˜ ì§ì „ í™•ì¸í•  í•µì‹¬ ìš”ì•½ì…ë‹ˆë‹¤.\n| **Clinical Scenario** | **Likely Physiology / Diagnosis** | **Key Action / Concept** |\n| --- | --- | --- |\n| **Pregnant, Cr 1.0 mg/dL** | **Pathologic** (Renal Insufficiency) | ì„ì‹  ì¤‘ ì •ìƒ Crì€ 0.4~0.8ì„. 1.0ì€ ë¹„ì •ìƒ. |\n| **Right Flank Pain, Mild Hydro** | **Physiologic Hydronephrosis** | Progesterone + Uterus ì••ë°•. reassurance (if no infection). |\n| **Back Pain, Waddling** | **Lordosis** (Hyper-lordosis) | MRI ê¸ˆì§€. Conservative management (Reassurance). |\n| **Trauma, Rh- Mom** | **Fetomaternal Hemorrhage** | **Kleihauer-Betke Test**ë¡œ ì¶œí˜ˆëŸ‰ í™•ì¸ í›„ RhoGAM ìš©ëŸ‰ ê²°ì •. |\n| **Induction â†’ Seizure/Confusion** | **Water Intoxication** | Oxytocinì´ **ADH**ì™€ êµì°¨ ë°˜ì‘í•˜ì—¬ Hyponatremia ìœ ë°œ. |\n| **Low Amniotic Fluid** | **Oligohydramnios** | ì›ì¸: Renal issue / Placental insufficiency. ê²°ê³¼: **Cord Compression** (Variable Decels). |\n**Verbatim Dictation (0:00 ~ 0:30)**\n\"Welcome back to the wards. Go ahead and drop your bag in the team room, maybe grab a coffee. We're getting right to work. Yep, time to prep. And today we're tackling an absolute monster of a topic. We are. We're opening up the Fetus section of the study stack for this deep dive. Our mission today is mastering the clinical logic behind sections 3.0 through 3.4. We're talking Gestational Age, Fetal Surveillance... The heart rate patterns that give everyone anxiety. And of course the absolute alphabet soup of prenatal testing.\"\n---\n# ğŸ“ **The Wards: Fetus Section (3.0 - 3.4) Study Stack**\n## 1. Introduction: The Fetus\nUSMLE Step 2 ì¤€ë¹„ë¥¼ ìœ„í•œ **Fetus Section (Section 3.0~3.4)** ê°•ì˜ë¡ì…ë‹ˆë‹¤.\nì„ìƒì ìœ¼ë¡œ ê°€ì¥ ê¸°ì´ˆê°€ ë˜ëŠ” **Gestational Age(ì¬íƒœì£¼ìˆ˜)**ë¶€í„°, ëª¨ë‘ë¥¼ ë¶ˆì•ˆí•˜ê²Œ ë§Œë“œëŠ” **Fetal Heart Rate Pattern**, ê·¸ë¦¬ê³  ë³µì¡í•œ **Prenatal Testing**ê¹Œì§€ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì•”ê¸°í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, *Clinical Logic*ì„ ì´í•´í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-37"}
{"chunk_type":"transcript_chunk","text":"---\n## 2. Section 3.1: Gestational Age (The Foundation)\nëª¨ë“  ì‚°ê³¼ì  ê²°ì •ì˜ ê¸°ì¤€ì´ ë˜ëŠ” ê°€ì¥ ì¤‘ìš”í•œ íŒŒíŠ¸ì…ë‹ˆë‹¤. ì•„ê¸°ê°€ Pre-termì¸ì§€ Post-termì¸ì§€, ì˜ ìë¼ê³  ìˆëŠ”ì§€ íŒë‹¨í•˜ë ¤ë©´ ì •í™•í•œ ë‚ ì§œê°€ í•„ìˆ˜ì…ë‹ˆë‹¤.\n### ğŸ“… The Dating Dilemma\n- **Clinical Scenario:** ìƒë¦¬ ì£¼ê¸°ê°€ ë¶ˆê·œì¹™í•œ í™˜ìê°€ ë‚´ì›í–ˆëŠ”ë°, ë§ˆì§€ë§‰ ìƒë¦¬ì¼(LMP) ê¸°ì¤€ìœ¼ë¡œëŠ” 14ì£¼ ê°™ì§€ë§Œ, Fundal heightëŠ” ì‘ê²Œ ëŠê»´ì§€ëŠ” ìƒí™©. ëˆ„êµ¬ë¥¼ ë¯¿ì–´ì•¼ í• ê¹Œìš”?\n- **The Golden Rule:** â˜… **History is useless, Trust the Tech.**\n- **Gold Standard:** **First Trimester Ultrasound** (íŠ¹íˆ **Crown Rump Length, CRL**).\n    - LMP(Last Menstrual Period)ëŠ” ë°°ë€ì¼ ë³€ë™, ë¶€ì •í™•í•œ ê¸°ì–µ ë“±ìœ¼ë¡œ ì¸í•´ ì˜¤ì°¨ê°€ í½ë‹ˆë‹¤.\n    - ë°˜ë©´, **First Trimester Ultrasound** (7~10ì£¼ ì‚¬ì´)ëŠ” ì˜¤ì°¨ ë²”ìœ„ê°€ **Â±3~5ì¼** ì •ë„ë¡œ ë§¤ìš° ì •ë°€í•©ë‹ˆë‹¤.\n    - ì´ë•Œ ì •í•´ì§„ Due Date(ì¶œì‚° ì˜ˆì •ì¼)ëŠ” ì„ì‹  ê¸°ê°„ ë‚´ë‚´ ë³€í•˜ì§€ ì•Šê³  ê³ ì •ë©ë‹ˆë‹¤(Locks in).\n### ğŸ“ Later in Pregnancy (No early US)\në§Œì•½ í™˜ìê°€ ì´ˆê¸° ì´ˆìŒíŒŒ ì—†ì´ ëŠ¦ê²Œ ë‚´ì›í–ˆë‹¤ë©´? **Fundal Height**ë¥¼ ì‚¬ìš©í•©ë‹ˆë‹¤.\n- **Rule:** 20ì£¼ ì´í›„ë¶€í„°ëŠ” **Fundal Height (cm) â‰ˆ Gestational Age (weeks)** (ì˜¤ì°¨ Â±2~3cm).\n- **Key Landmarks:**\n    - **Umbilicus (ë°°ê¼½):** ì•½ **20 Weeks**.\n    - **Xyphoid Process (ëª…ì¹˜):** ì•½ **36 Weeks**.\n- **âš ï¸ The Trap:** 40ì£¼ê°€ ë˜ë©´ íƒœì•„ê°€ ê³¨ë°˜ìœ¼ë¡œ ë‚´ë ¤ê°€ë©´ì„œ(Lightening/Engagement), Fundal heightê°€ ì˜¤íˆë ¤ 36ì£¼ ìˆ˜ì¤€ë³´ë‹¤ ë‚®ì•„ì§ˆ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ë¥¼ ì„±ì¥ ì§€ì—°ìœ¼ë¡œ ì°©ê°í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤.\n---\n## 3. Section 3.2: Fetal Surveillance (\"Is the baby okay?\")\nì—„ë§ˆê°€ \"ì•„ê¸°ê°€ ì˜ ì•ˆ ì›€ì§ì—¬ìš”\"ë¼ê³  í•  ë•Œ ê°€ì¥ ë¨¼ì € í•´ì•¼ í•  ì¼ì…ë‹ˆë‹¤.\n### ğŸ’“ Step 1: Non-Stress Test (NST)\n- **Target:** **Reactive NST**.\n- **Criterion (15x15 Rule):** 20ë¶„ ë™ì•ˆ **15 bpm ì´ìƒ ìƒìŠ¹**í•˜ëŠ” Accelerationì´ **15ì´ˆ ì´ìƒ ì§€ì†**ë˜ëŠ” ê²ƒì´ **2ë²ˆ ì´ìƒ** ë‚˜íƒ€ë‚˜ì•¼ í•¨.\n- **Physiology:** íƒœì•„ì˜ Sympathetic NS(êµê°ì‹ ê²½)ê°€ ì˜¨ì „í•˜ê³ , Brainstemì— ì‚°ì†Œê°€ ì˜ ê³µê¸‰ë˜ê³  ìˆë‹¤ëŠ” ëœ» (Neurologic check).\n- **Problem:** NSTê°€ **Non-reactive (Flat strip)**ì¼ ë•Œ.\n    - **Most Common Cause:** â˜… **Fetal Sleep Cycle** (ì•„ê¸°ê°€ ìê³  ìˆìŒ).\n    - **Action:** **Vibroacoustic Stimulation** (Buzzerë¡œ ê¹¨ìš°ê¸°) í˜¹ì€ ê²€ì‚¬ ì‹œê°„ì„ 40~60ë¶„ìœ¼ë¡œ ì—°ì¥.\n### ğŸ“Š Step 2: Biophysical Profile (BPP)\nNSTê°€ ì—¬ì „íˆ Non-reactiveë¼ë©´ **BPP**ë¡œ ë„˜ì–´ê°‘ë‹ˆë‹¤. (NST + Ultrasound)\n- **Scoring:** 5ê°€ì§€ í•­ëª© (ê° 0ì  or 2ì , ì´ 10ì  ë§Œì ).\n    1. **NST** (Reactive?)\n    2. **Fetal Breathing**\n    3. **Gross Body Movement**\n    4. **Fetal Tone** (Extension/Flexion)\n    5. **Amniotic Fluid Index (AFI)** â˜…\n- **Acute vs Chronic Markers:**\n    - **Acute Markers:** Tone, Movement, Breathing (ì €ì‚°ì†Œì¦ ì‹œ ë¹ ë¥´ê²Œ ì†Œì‹¤ë¨).\n    - **Chronic Marker:** â˜… **Amniotic Fluid (AFI)**.\n        - **Pathophysiology:** íƒœì•„ê°€ ë§Œì„±ì ì¸ Hypoxia ìƒíƒœë©´, ì¤‘ìš” ì¥ê¸°(Brain)ë¡œ í˜ˆë¥˜ë¥¼ ë³´ë‚´ê³  ì‹ ì¥(Kidney)ìœ¼ë¡œ ê°€ëŠ” í˜ˆë¥˜ë¥¼ ì¤„ì„ â†’ ì†Œë³€ëŸ‰ ê°ì†Œ â†’ **Oligohydramnios (ì–‘ìˆ˜ ê³¼ì†Œ)** ë°œìƒ.\n- **Management based on Score:**\n    - **8~10ì :** ì•ˆì‹¬ (Reassuring).\n    - **6ì :** ì• ë§¤í•¨ (Equivocal) â†’ 24ì‹œê°„ ë’¤ ì¬ê²€.\n    - **0~4ì :** ë¹„ì •ìƒ (Abnormal) â†’ â˜… **Immediate Delivery**.\n---\n## 4. Section 3.3: Fetal Heart Rate (Intrapartum Logic)\në¶„ë§Œ ì¤‘ íƒœì•„ ì‹¬ë°•ë™ ëª¨ë‹ˆí„°ë§ í•´ì„ì…ë‹ˆë‹¤.\n### ğŸ“ˆ Baseline & Abnormalities","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-47"}
{"chunk_type":"transcript_chunk","text":"- **Normal:** 110 ~ 160 bpm.\n- **Tachycardia (>160):** ê°€ì¥ í”í•œ ì›ì¸ì€ **Maternal Fever** (ì˜ˆ: **Chorioamnionitis**).\n- **Bradycardia (<110):** Maternal Hypothermia, Beta-blockers, í˜¹ì€ **Maternal Lupus (SLE)**.\n    - **SLE Connection:** ì—„ë§ˆì˜ Anti-Ro/La í•­ì²´ê°€ íƒœë°˜ì„ ê±´ë„ˆ íƒœì•„ì˜ ì „ë„ê³„(Conductive system)ë¥¼ ê³µê²© â†’ **Congenital Heart Block**.\n### ğŸ“‰ Decelerations (VEAL CHOP Logic)\n1. **Variable Decelerations (V)** â†’ **Cord Compression (C)**\n    - ëª¨ì–‘: ë‚ ì¹´ë¡œìš´ \"V\" ëª¨ì–‘ (Sharp drop).\n    - **Solution:** ê¸°ê³„ì ì¸ ë¬¸ì œ(ì¤„ ëˆŒë¦¼)ì´ë¯€ë¡œ ê¸°ê³„ì ìœ¼ë¡œ í•´ê²°. **Maternal Repositioning** (ì—„ë§ˆ ìì„¸ ë³€ê²½).\n2. **Early Decelerations (E)** â†’ **Head Compression (H)**\n    - ëª¨ì–‘: ìˆ˜ì¶•ê³¼ í•¨ê»˜ ë–¨ì–´ì§€ê³  ìˆ˜ì¶•ê³¼ í•¨ê»˜ íšŒë³µ (Mirror image).\n    - **Meaning:** ì•„ê¸° ë¨¸ë¦¬ê°€ ê³¨ë°˜ì— ë¼ë©´ì„œ ëˆŒë¦¬ëŠ” ê²ƒ. **Physiologic (ì •ìƒ)**. ê·¸ëƒ¥ ì§€ì¼œë³´ë©´ ë¨.\n3. **Late Decelerations (L)** â†’ **Placental Insufficiency (P)** â˜… (Emergency)\n    - ëª¨ì–‘: ìˆ˜ì¶•ì´ ì •ì (Peak)ì„ ì°ì€ *ë’¤ì—* ì‹¬ë°•ìˆ˜ê°€ ë–¨ì–´ì§€ê¸° ì‹œì‘í•¨.\n    - **Pathophysiology:** íƒœë°˜ ê¸°ëŠ¥ ë¶€ì „ìœ¼ë¡œ ìˆ˜ì¶• ì‹œ ì‚°ì†Œ ê³µê¸‰ì´ ì•ˆ ë¨.\n    - **Action:** **Intrauterine Resuscitation**.\n        1. **O2** ê³µê¸‰.\n        2. **IV Fluids** (í˜ˆë¥˜ëŸ‰ ì¦ê°€).\n        3. **Reposition** (íƒœë°˜ ì••ë°• í•´ì œ).\n        4. **Stop Pitocin (Oxytocin)** (ìˆ˜ì¶• ì¤‘ë‹¨).\n    - ê·¸ë˜ë„ ì•ˆ ë˜ë©´? â†’ **C-Section**.\n4. **Sinusoidal Pattern** â†’ **Anemia (Fetal)**\n    - ëª¨ì–‘: ë¶€ë“œëŸ¬ìš´ Sine íŒŒí˜• (Smooth sine wave).\n    - **Meaning:** íƒœì•„ì˜ ê·¹ì‹¬í•œ ë¹ˆí˜ˆ(Severe Anemia/Hypoxia). ë‡Œê°€ ì‹¬ë°• ì¡°ì ˆ ëŠ¥ë ¥ì„ ìƒìŒ. **Red Alert!** (ì˜ˆ: Vasa Previa í„°ì§, Rh incompatibility ë“±).\n---\n## 5. Section 3.4: Prenatal Testing (Alphabet Soup)\nScreening(ì„ ë³„ ê²€ì‚¬)ê³¼ Diagnostic(í™•ì§„ ê²€ì‚¬)ì„ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\n### ğŸ©¸ Routine Labs (Initial Visit)\n- Blood Type & Rh Status (Rh- í™•ì¸).\n- Infection Screen: HIV, Syphilis, Hep B, Rubella/Varicella immunity.\n- **Urine Culture:** ì¦ìƒì´ ì—†ì–´ë„(**Asymptomatic**) ë°˜ë“œì‹œ ì¹˜ë£Œí•´ì•¼ í•¨ (â†’ **Pyelonephritis** ì§„í–‰ ìœ„í—˜ ë†’ìŒ).\n### ğŸ•° Timeline Specifics\n- **24~28 Weeks:** **Gestational Diabetes Screen** (1hr Glucose Challenge Test). ì‹¤íŒ¨ ì‹œ 3hr í™•ì§„ ê²€ì‚¬. (Rh- ì‚°ëª¨ëŠ” ì´ë•Œ Antibody screen ì¬ê²€).\n- **35~37 Weeks:** **GBS (Group B Strep) Swab**.\n    - Positive ì‹œ: ë¶„ë§Œ ì¤‘ **Intrapartum Antibiotics (Penicillin)** íˆ¬ì—¬.\n### ğŸ§¬ Aneuploidy Screening (Down Syndrome ë“±)\n- **First Trimester Screen:**\n    - PAPP-A + Beta-hCG + **Nuchal Translucency (NT)**.\n    - Down Syndrome Pattern: **High hCG**, **Low PAPP-A**, **Thick Nuchal Translucency**.\n- **Cell-Free DNA (NIPT):** ì •í™•ë„ê°€ ë§¤ìš° ë†’ì§€ë§Œ ì—¬ì „íˆ **Screening** Testì„. ì–‘ì„±ì´ ë‚˜ì˜¤ë©´ ë°˜ë“œì‹œ í™•ì§„ ê²€ì‚¬ê°€ í•„ìš”í•¨.\n- **Second Trimester (Quad Screen):**\n    - **Trisomy 21 (Downs):** **HI**gh markers (**H**CG, **I**nhibin A) / Low markers (AFP, Estriol). (**HI** = **Hi**gh).\n    - **Trisomy 18 (Edwards):** **E**verything is **low** & depressed (AFP, Estriol, hCG, Inhibin A ëª¨ë‘ ë‚®ìŒ).\n- **Diagnostic Tests (Confirmation):**\n    - 10~13ì£¼: **CVS (Chorionic Villus Sampling)**.\n    - 15~20ì£¼: **Amniocentesis (ì–‘ìˆ˜ì²œì)**.\n---","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-67"}
{"chunk_type":"recap_summary","text":"# ğŸ”¥ Rapid Fire Recap\nê°•ì˜ì—ì„œ ë‹¤ë£¬ í•µì‹¬ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ì •ë¦¬í•©ë‹ˆë‹¤.\n1. **Dating Dilemma**\n    - **Scenario:** LMP vs Ultrasound ë‚ ì§œ ë¶ˆì¼ì¹˜ (íŠ¹íˆ 1ë¶„ê¸°).\n    - **Action:** â˜… **Trust the Ultrasound (CRL)**. Due dateëŠ” í•œ ë²ˆ ì •í•´ì§€ë©´ ë°”ë€Œì§€ ì•ŠìŒ.\n2. **Fetal Surveillance**\n    - **Scenario:** \"Baby isn't moving\" (Decreased fetal movement).\n    - **Action:** **NST** ë¨¼ì € ì‹œí–‰.\n    - **Result:** Non-reactive (No accelerations).\n    - **Next Step:** Vibroacoustic stimulation (Wake up baby) â†’ ê·¸ë˜ë„ ì•ˆ ë˜ë©´ **BPP**.\n    - **BPP Score:** 4ì  ì´í•˜ëŠ” **Immediate Delivery**.\n3. **Intrapartum Decelerations (VEAL CHOP)**\n    - **Variable Decels** â†’ **Cord Compression** â†’ **Reposition Mom**.\n    - **Late Decels** â†’ **Placental Insufficiency** â†’ **Intrauterine Resuscitation** (O2, IV, Stop Pitocin) â†’ Failì‹œ C-Section.\n    - **Sinusoidal** â†’ **Severe Fetal Anemia** â†’ Emergency.\n4. **Prenatal Genetic Screening**\n    - **Fact:** **NIPT** (Cell-free DNA)ëŠ” ì •í™•í•˜ì§€ë§Œ **Screening**ì´ë‹¤. í™•ì§„ì„ ìœ„í•´ì„œëŠ” **CVS**ë‚˜ **Amnio**ê°€ í•„ìš”í•˜ë‹¤.\n    - **Down Syndrome Pattern (Quad):** **HI**gh levels of **H**CG & **I**nhibin A.\n**Verbatim Dictation (0:00 ~ 0:30)**\n\"Welcome back. Today we're digging into a topic that's, well, it's absolutely critical in obstetrics. It really is. We're talking about congenital infections and screening. This is where, you know, maternal health and fetal outcomes collide and the margin for error is just so thin. Exactly. We're focusing on sections 4 through 4.6 of the material today. This is the bread and butter for the boards but it's also... I mean it's all about pattern recognition for real world practice. Pattern recognition, I like that. Yeah. You have to know who to screen, when to screen, and most importantly, how to stop that vertical transmission dead in its tracks.\"\n---\n# ğŸ“š USMLE Step 2 CK: Congenital Infections & Screening (Section 4 - 4.6)\nì•ˆë…•í•˜ì„¸ìš”! USMLE Step 2 ì¤€ë¹„í•˜ì‹œëŠë¼ ê³ ìƒ ë§ìœ¼ì‹­ë‹ˆë‹¤. ì—…ë¡œë“œí•´ì£¼ì‹  ì˜¤ë””ì˜¤ íŒŒì¼ì€ **Prenatal Screeningê³¼ Congenital Infections**ì— ëŒ€í•œ í•µì‹¬ ë‚´ìš©, íŠ¹íˆ **Vertical Transmission(ìˆ˜ì§ ê°ì—¼)**ì„ ë§‰ê¸° ìœ„í•œ Timingê³¼ Managementë¥¼ ë‹¤ë£¨ê³  ìˆìŠµë‹ˆë‹¤.\nìš”ì²­í•˜ì‹  ëŒ€ë¡œ **Top-down Classification (Structure)**ì„ ë¨¼ì € ë³´ì—¬ë“œë¦¬ê³ , ê° ì„¹ì…˜ë³„ í•µì‹¬ ë‚´ìš©ì„ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\n## ğŸŒ³ Big Picture: Prenatal Screening Logic Tree","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-80"}
{"chunk_type":"transcript_chunk","text":"ì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ \"Pattern Recognition\"ì„ ìœ„í•œ Mental Modelì…ë‹ˆë‹¤. ëˆ„êµ¬ë¥¼ ì–¸ì œ ìŠ¤í¬ë¦¬ë‹í•˜ê³  ì–´ë–»ê²Œ ë§‰ì„ ê²ƒì¸ê°€ì— ëŒ€í•œ êµ¬ì¡°ë„ì…ë‹ˆë‹¤.\nPlaintex\n`PRENATAL INFECTION SCREENING & MANAGEMENT\nâ”‚\nâ”œâ”€â”€ 1. Universal Screening (The \"Dragnet\" - First Visit)\nâ”‚   â”œâ”€â”€ Goal: ëª¨ë“  ì„ì‚°ë¶€ ëŒ€ìƒ ê¸°ë³¸ ê²€ì‚¬\nâ”‚   â”œâ”€â”€ Target Pathogens:\nâ”‚   â”‚   â”œâ”€â”€ HIV\nâ”‚   â”‚   â”œâ”€â”€ Syphilis (VDRL/RPR)\nâ”‚   â”‚   â”œâ”€â”€ Hepatitis B (HBsAg)\nâ”‚   â”‚   â””â”€â”€ Immunity Check: Rubella & Varicella\nâ”‚   â””â”€â”€ Action: ë©´ì—­ ì—†ìœ¼ë©´ ì¶œì‚° ì§í›„ ë°±ì‹  ì ‘ì¢… (ì„ì‹  ì¤‘ Live ë°±ì‹  ê¸ˆì§€!)\nâ”‚\nâ”œâ”€â”€ 2. High-Risk Screening (\"Widening the Aperture\")\nâ”‚   â”œâ”€â”€ Goal: Risk Factorê°€ ìˆëŠ” ì‚°ëª¨ ëŒ€ìƒ ì¶”ê°€ ê²€ì‚¬\nâ”‚   â”œâ”€â”€ Target Pathogens:\nâ”‚   â”‚   â”œâ”€â”€ Chlamydia & Gonorrhea (PCR)\nâ”‚   â”‚   â””â”€â”€ Hepatitis C, TB, etc.\nâ”‚   â””â”€â”€ Timing: \nâ”‚       â”œâ”€â”€ 1st Trimester (ì´ˆê¸°)\nâ”‚       â””â”€â”€ 3rd Trimester (Repeat screening at 28-32w) â˜… ì¤‘ìš”!\nâ”‚           (ì´ìœ : Window period ê³ ë ¤, ì„ì‹  ì¤‘ ì¬ê°ì—¼ ê°€ëŠ¥ì„±)\nâ”‚\nâ”œâ”€â”€ 3. Time-Sensitive Screening (Specific Windows)\nâ”‚   â””â”€â”€ GBS (Group B Strep): 36-38 Weeks (Transient colonization íŠ¹ì„± ë•Œë¬¸)\nâ”‚\nâ””â”€â”€ 4. Intrapartum Management (Delivery Room Decisions)\n    â”œâ”€â”€ Active HSV Lesions â†’ C-Section Mandatory\n    â”œâ”€â”€ HIV Viral Load > 1,000 â†’ C-Section Mandatory\n    â””â”€â”€ Syphilis/GBS Positive â†’ Intrapartum Penicillin`\n---\n## 1. Section 4: Congenital Infections Overview\nì„ì‹  ì¤‘ ê°ì—¼ ê´€ë¦¬ëŠ” **Prevention**ê³¼ **Screening Timing**ì´ í•µì‹¬ì…ë‹ˆë‹¤.\n### ğŸš© Screening Protocol\n- **Universal Screen (The Dragnet):** ëª¨ë“  ì‚°ëª¨ëŠ” ì²« ë°©ë¬¸ ì‹œ HIV, Syphilis, Hep B, Rubella/Varicella immunityë¥¼ ê²€ì‚¬í•©ë‹ˆë‹¤.\n- **High Risk Patients:** ë‚˜ì´ê°€ ì–´ë¦¬ê±°ë‚˜ (<25ì„¸), STIs ê³¼ê±°ë ¥ì´ ìˆëŠ” ê²½ìš° **Chlamydia & Gonorrhea** ìŠ¤í¬ë¦¬ë‹ì„ ì¶”ê°€í•©ë‹ˆë‹¤.\n    - â˜… **Key Point:** High risk í™˜ìëŠ” ì„ì‹  ì´ˆê¸° ìŒì„±ì´ë”ë¼ë„, **3rd Trimesterì— ì¬ê²€ì‚¬(Repeat screening)**ê°€ í•„ìˆ˜ì…ë‹ˆë‹¤. (Infectionì´ ì„ì‹  ì¤‘ê°„ì— ìƒê¸¸ ìˆ˜ ìˆìŒ)\n### ğŸ’‰ Vaccination Rules (Strict Guidelines)\nì˜¤ë””ì˜¤ì—ì„œ \"Hard Line\"ì´ë¼ê³  í‘œí˜„í•  ì •ë„ë¡œ ì—„ê²©í•œ ê·œì¹™ì…ë‹ˆë‹¤.\n| **Vaccine Type** | **Examples** | **Pregnancy Status** | **Reasoning** |\n| --- | --- | --- | --- |\n| **Live Attenuated** | **MMR, Varicella, Live Flu (Intranasal)** | âŒ **CONTRAINDICATED** | ì´ë¡ ì ìœ¼ë¡œ íƒœë°˜ì„ í†µê³¼í•´ íƒœì•„ ê°ì—¼ ê°€ëŠ¥ì„± ìˆìŒ (Risk of vertical transmission) |\n| **Inactivated / Toxoid** | **Tdap, Hep B, Inactivated Flu** | âœ… **SAFE / INDICATED** | Tdapì€ í•„ìˆ˜, ë‚˜ë¨¸ì§€ëŠ” Riskì— ë”°ë¼ ì ‘ì¢… ê°€ëŠ¥ |\n| **Special Situations** | Meningococcus, Pneumococcus, Hep A | âœ… Considered | High risk ìƒí™©ì¼ ê²½ìš° Benefit > Risk |\n---\n## 2. Section 4.1: Group B Strep (GBS)\nGBSëŠ” **Neonatal Sepsis**ì˜ ê°€ì¥ í”í•œ ì›ì¸ê· ì…ë‹ˆë‹¤.\n- **Why wait? (Timing is Key):** GBSëŠ” **Transient**í•©ë‹ˆë‹¤(ì™”ë‹¤ ê°”ë‹¤ í•¨). ì„ì‹  30ì£¼ì— ê²€ì‚¬í•˜ëŠ” ê±´ ì˜ë¯¸ê°€ ì—†ìŠµë‹ˆë‹¤. ë¶„ë§Œ ì‹œì ì— ê· ì´ ìˆëŠ”ì§€ ì•„ëŠ” ê²ƒì´ ì¤‘ìš”í•˜ë¯€ë¡œ **36~38ì£¼** ì‚¬ì´ì— ê²€ì‚¬í•©ë‹ˆë‹¤.\n- **Screening Method:** Rectovaginal culture.\n- **Treatment:** Culture Positiveë©´ ë¶„ë§Œ ì¤‘(Intrapartum) **Penicillin** (or Ampicillin) íˆ¬ì—¬.\n- **â“ Scenario: Preterm Labor (<37 weeks) with Unknown GBS Status**\n    - ê²€ì‚¬ ê²°ê³¼ê°€ ë‚˜ì˜¬ ë•Œê¹Œì§€ ê¸°ë‹¤ë¦´ ì‹œê°„ì´ ì—†ìŠµë‹ˆë‹¤. Preemie(ë¯¸ìˆ™ì•„)ëŠ” ê°ì—¼ì— ë§¤ìš° ì·¨ì•½í•©ë‹ˆë‹¤.\n    - **Action:** ë¬´ì¡°ê±´ **Treat immediately** (Start Penicillin). ë‚˜ì¤‘ì— ìŒì„± ë‚˜ì˜¤ë©´ ëŠë”ë¼ë„ ì¼ë‹¨ ì‹œì‘í•©ë‹ˆë‹¤.\n---\n## 3. Section 4.2: Syphilis (The \"Great Imitator\")\nìµœê·¼ ë‹¤ì‹œ ê¸‰ì¦í•˜ê³  ìˆëŠ” ì§ˆí™˜ì´ë©°, ì„ ì²œì„± ê°ì—¼ ì‹œ ê²°ê³¼ê°€ ì¹˜ëª…ì ì…ë‹ˆë‹¤.\n### ğŸ‘¶ Congenital Syphilis Signs\n- **Snuffles:** ì§€ì†ì ì¸ ì½§ë¬¼ (Persistent runny nose)\n- **Saber Shins:** ì •ê°•ì´ ë¼ˆê°€ ì•ìœ¼ë¡œ íœ˜ì–´ì§ (Tibia bows forward)\n- **Hutchinson Teeth:** í†±ë‹ˆ ëª¨ì–‘ì˜ ì•ë‹ˆ (Notched peg-shaped incisors)","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-90"}
{"chunk_type":"transcript_chunk","text":"### ğŸ§ª Diagnosis Step-by-Step\n1. **Screening (Non-treponemal):** **VDRL** or **RPR**.\n    - **False Positive ì£¼ì˜:** ì„ì‹  ìì²´(Pregnancy), Lupus(SLE) ë“±ì—ì„œ ìœ„ì–‘ì„±ì´ ë‚˜ì˜¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤. (ì—¼ì¦ ë°˜ì‘ë§Œ ë³´ëŠ” ê²ƒì„)\n2. **Confirmation (Treponemal):** **FTA-ABS**. (Specific antibody test)\n    - Screening ì–‘ì„±ì´ë©´ ë°˜ë“œì‹œ í™•ì§„ ê²€ì‚¬ë¥¼ í•´ì•¼ í•©ë‹ˆë‹¤.\n    - í™•ì§„ í›„ì—ëŠ” **Darkfield Microscopy**ë¡œ ê· (Spirochetes)ì„ ì§ì ‘ ë³¼ ìˆ˜ë„ ìˆìŠµë‹ˆë‹¤.\n### ğŸ’Š Treatment & Dilemma\n- **Drug of Choice:** **Penicillin G**.\n- **â“ Scenario: Penicillin Allergyê°€ ìˆëŠ” ì„ì‚°ë¶€ë¼ë©´?**\n    - ë‹¤ë¥¸ ëŒ€ì•ˆ(Doxycycline ë“±)ì€ íƒœì•„ì—ê²Œ í•´ë¡­ê±°ë‚˜(Teeth discoloration) íš¨ê³¼ê°€ ë¶ˆí™•ì‹¤í•©ë‹ˆë‹¤.\n    - **Action:** **Desensitization (íƒˆê°ì‘)** í›„ Penicillinì„ íˆ¬ì—¬í•©ë‹ˆë‹¤. ì´ê²Œ ìœ ì¼í•œ ë°©ë²•ì…ë‹ˆë‹¤ (\"No alternative\").\n---\n## 4. Section 4.3: Rubella (German Measles)\n### ğŸš¨ Congenital Rubella Syndrome Triad (The 3 C's)\n1. **Cataracts** (White pupils) 2. **Cochlear defects** (Deafness)\n2. **Cardiac abnormalities** (ì£¼ë¡œ **PDA**)\n### ğŸ“… Timing & Management\n- **Infection < 16 Weeks:** íƒœì•„ì—ê²Œ ì¹˜ëª…ì (Catastrophic). ê¸°í˜• ë°œìƒ í™•ë¥  ë§¤ìš° ë†’ìŒ. â†’ **Counsel on Termination** ê³ ë ¤.\n- **Infection > 16 Weeks:** Riskê°€ ë‚®ì•„ì§. â†’ Reassurance.\n- **Prevention Strategy:**\n    - ì„ì‹  ì „ í˜¹ì€ ì²« ë°©ë¬¸ ì‹œ Rubella IgG(Immunity) í™•ì¸.\n    - **Non-immune ì‚°ëª¨:** ì„ì‹  ì¤‘ì—ëŠ” ë°±ì‹ (MMR) ì ‘ì¢… ë¶ˆê°€(Live vaccine). **ì¶œì‚° ì§í›„(Postpartum)** í‡´ì›í•˜ê¸° ì „ì— ë°±ì‹ ì„ ë§ì¶¥ë‹ˆë‹¤.\n---\n## 5. Section 4.4: HSV (Herpes Simplex Virus)\nì‹ ìƒì•„ì—ê²ŒëŠ” Brain, Skin, Eyesì— ì¹˜ëª…ì ì¸ ê°ì—¼ì„ ì¼ìœ¼í‚¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n- **The Rule:** ë¶„ë§Œ ì‹œì ì— **Active Genital Lesions**ì´ ìˆê±°ë‚˜ **Prodromal symptoms**(íƒ€ëŠ” ë“¯í•œ ëŠë‚Œ ë“±)ì´ ìˆìœ¼ë©´?\n- **Action:** **C-Section Mandatory**. (Vaginal delivery ê¸ˆì§€).\n- **Prophylaxis:** ì¬ë°œ ë°©ì§€ë¥¼ ìœ„í•´ ì„ì‹  36ì£¼ë¶€í„° Acyclovir ì˜ˆë°© ìš”ë²•ì„ í•˜ê¸°ë„ í•©ë‹ˆë‹¤ (ì˜¤ë””ì˜¤ì—ëŠ” êµ¬ì²´ì  ì•½ë¬¼ ì–¸ê¸‰ë³´ë‹¤ C-sec ê°•ì¡°ë¨).\n---\n## 6. Section 4.6: HIV\nê°€ì¥ ê·œì •ì´ ì—„ê²©í•˜ì§€ë§Œ, ê´€ë¦¬ë§Œ ì˜í•˜ë©´ ìˆ˜ì§ ê°ì—¼ì„ ê±°ì˜ 0%ë¡œ ë§Œë“¤ ìˆ˜ ìˆëŠ” ë¶„ì•¼ì…ë‹ˆë‹¤.\n### ğŸ”¢ The Magic Number: 1,000 copies/mL\nViral Load(ë°”ì´ëŸ¬ìŠ¤ ìˆ˜ì¹˜)ê°€ **1,000**ì„ ê¸°ì¤€ìœ¼ë¡œ ëª¨ë“  ê²ƒì´ ê²°ì •ë©ë‹ˆë‹¤.\n| **Viral Load** | **Delivery Method** | **Management** |\n| --- | --- | --- |\n| **> 1,000 copies/mL** | **C-Section Mandatory** | Vaginal delivery ì‹œ ê°ì—¼ ìœ„í—˜ ë„ˆë¬´ ë†’ìŒ. Zidovudine(AZT) IV during labor. |\n| **< 1,000 copies/mL** (on HAART) | **Vaginal Delivery OK** | ì•½ ì˜ ë¨¹ê³  ë°”ì´ëŸ¬ìŠ¤ ì–µì œë˜ë©´ ìì—°ë¶„ë§Œ ì•ˆì „í•¨. |","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-110"}
{"chunk_type":"transcript_chunk","text":"### ğŸš« Intrapartum \"Don'ts\" (ê¸ˆê¸°ì‚¬í•­)\nì‚°ëª¨ì˜ í˜ˆì•¡ê³¼ íƒœì•„ì˜ í˜ˆì•¡ì´ ì„ì´ëŠ” ìƒí™©ì„ í”¼í•´ì•¼ í•©ë‹ˆë‹¤.\n- NO Artificial Rupture of Membranes (ì–‘ë§‰ ì¸ê³µ íŒŒì—´ ê¸ˆì§€ - ê°€ëŠ¥í•œ í•œ ëŠ¦ê²Œ)\n- NO Fetal Scalp Electrodes (íƒœì•„ ë¨¸ë¦¬ì— ì „ê·¹ ê½‚ê¸° ê¸ˆì§€)\n- NO Vacuum or Forceps (ê¸°êµ¬ ë¶„ë§Œ ê¸ˆì§€)\n### ğŸ‘¶ Infant Diagnosis\n- **Mom's IgG crosses the placenta:** ì—„ë§ˆì˜ í•­ì²´ê°€ ì•„ê¸°ì—ê²Œ ë„˜ì–´ê°€ë¯€ë¡œ, ì•„ê¸°ì—ê²Œ í•­ì²´ ê²€ì‚¬(ELISA/Western Blot)ë¥¼ í•˜ë©´ **ë¬´ì¡°ê±´ ì–‘ì„±** ë‚˜ì˜µë‹ˆë‹¤ (ìµœëŒ€ 18ê°œì›”ê¹Œì§€).\n- **Action:** ì•„ê¸°ì˜ ì§„ë‹¨ì€ **HIV DNA PCR** (ë°”ì´ëŸ¬ìŠ¤ ìì²´ ê²€ì¶œ)ë¡œ í•´ì•¼ í•©ë‹ˆë‹¤.\n---\n## ğŸ”¥ Rapid Fire Recap (ìš”ì•½)\nì˜¤ë””ì˜¤ì˜ ë§ˆì§€ë§‰ í€´ì¦ˆ ì„¹ì…˜ì„ ì •ë¦¬í–ˆìŠµë‹ˆë‹¤.\n- **Scenario 1:** ì‹ ìƒì•„ê°€ ë°±ë‚´ì¥(Cataracts), ë‚œì²­(Deafness), ì‹¬ì¥ ê¸°í˜•(PDA)ì„ ë³´ì„.\n    - ğŸ‘‰ **Diagnosis:** **Congenital Rubella Syndrome**.\n- **Scenario 2:** ì‹ ìƒì•„ê°€ ì½§ë¬¼(Snuffles), ì •ê°•ì´ íœ¨(Saber shins), Hutchinson teethë¥¼ ë³´ì„.\n    - ğŸ‘‰ **Diagnosis:** **Congenital Syphilis**.\n- **Scenario 3:** ì„ì‚°ë¶€ Syphilis ì–‘ì„±ì¸ë° Penicillin Allergyê°€ ìˆìŒ.\n    - ğŸ‘‰ **Key Action:** **Desensitization** í›„ Penicillin íˆ¬ì—¬ (Don't switch drugs).\n- **Scenario 4:** HIV ì‚°ëª¨, Viral load < 1,000 copies. ë¶„ë§Œ ë°©ë²•ì€?\n    - ğŸ‘‰ **Key Action:** **Vaginal Delivery** ê°€ëŠ¥.\n- **Scenario 5:** Preterm labor (33ì£¼), GBS ìƒíƒœ ëª¨ë¦„.\n    - ğŸ‘‰ **Key Action:** ì¼ë‹¨ **Penicillin** ì‹œì‘ (Treat as positive).\n- **Scenario 6:** ì„ì‹  ì¤‘ MMR ë°±ì‹  ì ‘ì¢… ê°€ëŠ¥?\n    - ğŸ‘‰ **Fact:** ì ˆëŒ€ ë¶ˆê°€ (**Live Vaccine** Contraindicated). ì¶œì‚° í›„ ì ‘ì¢….\n---\n**Would you like me to create a specific Anki card style Q&A list for these infection protocols to help with your spaced repetition?**\n### Summary & Vibe\n**One Line Vibe:** ë¼ìš´ë”© ì „ 18ë¶„, ì—ìŠ¤í”„ë ˆì†Œ í•œ ì”ê³¼ í•¨ê»˜ OBGYN High-yield \"Scary Stuff\" ì™„ë²½ ì •ë¦¬! â˜•ğŸ¥\n---\n### **Verbatim Dictation (0:00 ~ 0:30)**\n\"All right, I've got the double espresso in hand. Looking at the clock, we have what exactly 18 minutes before we have to be on the floor for rounds? It's 18 minutes, that's plenty of time. I feel like this is the perfect window to solidify some of the heavier obstetric topics before the day gets, you know, chaotic. It is. And honestly, we don't need to rehash the basics of normal labor today. I want to use this time to solidify the scary stuff, the middle of the night calls.\"\n---\n### **Medical Concept Tree (Top-down Classification)**\nPlaintext\n`Obstetrics (High-Yield Pathology)\nâ”œâ”€â”€ Section 5: IUGR (Intrauterine Growth Restriction)\nâ”‚   â”œâ”€â”€ Etiology: Maternal HTN â†’ Placental Insufficiency\nâ”‚   â”œâ”€â”€ Pathophysiology:\nâ”‚   â”‚   â”œâ”€â”€ Brain Sparing Effect (Shunt blood to vital organs)\nâ”‚   â”‚   â””â”€â”€ Renal hypoperfusion â†’ Oligohydramnios\nâ”‚   â””â”€â”€ Management Decision: Umbilical Artery Doppler (Resistance Gauge)\nâ”‚       â”œâ”€â”€ High Resistance: Monitor\nâ”‚       â””â”€â”€ Reverse End-Diastolic Flow: Immediate Delivery (C-Sec)\nâ”‚\nâ”œâ”€â”€ Section 6: Twins (Multiple Gestation)\nâ”‚   â”œâ”€â”€ Risks: Hyperemesis (â†‘hCG), Pre-eclampsia (â†‘Placental mass), Vasa Previa\nâ”‚   â”œâ”€â”€ Delivery Management (Based on Twin A)\nâ”‚   â”‚   â”œâ”€â”€ Twin A Vertex: Vaginal Delivery possible (even if B is breech)\nâ”‚   â”‚   â””â”€â”€ Twin A Breech: C-Section\nâ”‚   â””â”€â”€ Contraindications: External Cephalic Version (ECV) - Absolute NO\nâ”‚\nâ”œâ”€â”€ Section 7: IUFD (Intrauterine Fetal Demise)\nâ”‚   â”œâ”€â”€ Diagnosis: Real-time Ultrasound (Absence of cardiac activity)\nâ”‚   â”œâ”€â”€ Management: Vaginal Delivery (Induction) > C-Section\nâ”‚   â”‚   â””â”€â”€ Why? Protect future reproductive health (avoid uterine scar)\nâ”‚   â””â”€â”€ Complications: DIC (Thromboplastin release from retained fetus)\nâ”‚\nâ””â”€â”€ Section 8: Hydrops Fetalis\n    â”œâ”€â”€ Definition: Fluid in 2+ compartments (Skin edema, ascites, effusion)\n    â”œâ”€â”€ Mechanism: High Output Heart Failure (Severe Anemia)\n    â””â”€â”€ Causes:\n        â”œâ”€â”€ Immune: Rh Incompatibility\n        â””â”€â”€ Non-Immune: Parvovirus B19 (BM suppression), Alpha-Thalassemia (Hb Barts)`","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-130"}
{"chunk_type":"transcript_chunk","text":"---\n# [Sections 5-8] Managing IUGR, Twins, Demise, and Hydrops\n## 1. Introduction\n- **Context:** ë¼ìš´ë”© ì‹œì‘ ì „ 18ë¶„ ë™ì•ˆ **\"The Scary Stuff\"** (ë°¤ ë‹¹ì§ ë•Œ ì½œ ë°›ëŠ” ì‘ê¸‰ ìƒí™©ë“¤)ë¥¼ ì •ë¦¬í•˜ëŠ” ì‹œê°„.\n- **Topics:** Normal laborëŠ” ìŠ¤í‚µí•˜ê³ , IUGR, Twins, Fetal Demise, Hydrops ê°™ì€ High-yield pathologyì— ì§‘ì¤‘.\n---\n## 2. Section 5: IUGR (Intrauterine Growth Restriction)\n> \"The placenta giving up\"\n>\n**Clinical Scenario:**\n- 32ì£¼ ì‚°ëª¨, **Chronic Hypertension** history.\n- **Fundal height**ê°€ 4cm ì •ë„ ì‘ê²Œ ì¸¡ì •ë¨ (Lagging behind).\n**Workup Flow:**\n1. **Initial:** Bio-physical Profile (BPP) & Ultrasound (Estimated Fetal Weight < 10th percentile).\n2. **Most Critical Step:** â˜… **Umbilical Artery Doppler**\n    - DopplerëŠ” Placental bedì˜ **Resistance**ë¥¼ ì¸¡ì •í•˜ëŠ” Pressure gauge ì—­í• ì„ í•¨.\n    - Healthy Placenta = Low resistance sponge (íƒœì•„ ì‹¬ì¥ ì´ì™„ê¸°ì—ë„ íƒœì•„ì—ì„œ íƒœë°˜ìª½ìœ¼ë¡œ í”¼ê°€ ì˜ íë¦„).\n    - Calcified/Old Placenta (HTN) = High resistance brick. (íƒœë°˜ ì••ë ¥ì´ ë†’ì•„ì„œ íƒœì•„ ì‹¬ì¥ ì´ì™„ê¸°ë§Œí¼ ë†’ì•„ì§€ë©´ íƒœì•„ìª½ì—ì„œ íƒœë°˜ìª½ìœ¼ë¡œ í”¼ê°€ ì•ˆê°)\n**Doppler Findings & Management:**\n- **Reduced Diastolic Flow:** Resistanceê°€ ì˜¬ë¼ê°€ì„œ ì´ì™„ê¸°ì— í”¼ê°€ ì˜ ì•ˆ ê°. (ì••ë ¥ì´ ë†’ì•„ì„œ íƒœì•„ì—ì„œ íƒœë°˜ìœ¼ë¡œ ì˜ ì•ˆê°„ë‹¤)\n- **Absent End-Diastolic Flow:** ì´ì™„ê¸°ì— í”¼ê°€ ë©ˆì¶¤. íƒœë°˜ ì••ë ¥ì´ íƒœì•„ ì‹¬ì¥ ì´ì™„ê¸°ì••ë ¥ë§Œí¼ ë†’ì•„ì ¸ì„œ ì•ˆê°. í‰í˜•ì„ ì´ë£¬ìƒíƒœ\n- **Reverse End-Diastolic Flow (The Ominous Sign):**\n    - íƒœì•„ ìª½ ì••ë ¥ë³´ë‹¤ íƒœë°˜ ì €í•­ì´ ë” ì»¤ì„œ í”¼ê°€ íƒœì•„ ìª½ìœ¼ë¡œ ì—­ë¥˜í•¨.\n    - **Action:** â˜… **Immediate Delivery (usually C-section)**. íƒœì•„ê°€ ìˆ¨ì„ ëª» ì‰¬ëŠ” ìƒíƒœ(Suffocating).\n**Pathophysiology (Why Oligohydramnios?):**\n- **Brain Sparing Effect:** Fetusê°€ Hypoxiaë¥¼ ê°ì§€í•˜ë©´ Vital organs (Brain, Heart)ë¡œ í”¼ë¥¼ ëª°ì•„ì¤Œ (Sympathetic response).\n    - Kidneyë¡œ ê°€ëŠ” í˜ˆë¥˜ ê°ì†Œ  â†’ Urine production ê°ì†Œ  â†’ Amniotic fluid (mostly fetal urine) ê°ì†Œ  â†’ **Oligohydramnios**.\n---\n## 3. Section 6: Twins\n> \"The Risk Multiplier\"\n>\n**Key Physiological Changes:**\n- **Hyperemesis Gravidarum:** Placental massê°€ ì»¤ì„œ **hCG**ê°€ í­ë°œì ìœ¼ë¡œ ì¦ê°€  â†’ ì‹¬í•œ êµ¬í† .\n- **Pre-eclampsia:** Placental mass ì¦ê°€ë¡œ ì¸í•œ Vascular strain  â†’ ì‚°ëª¨ì˜ ê³ í˜ˆì•• ìœ„í—˜ ê¸‰ì¦.","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-150"}
{"chunk_type":"transcript_chunk","text":"**Delivery Management Dilemma (Board Trap! ğŸš©):**\nTwin A(ì•„ë˜ìª½ ì•„ê¸°)ì˜ ìœ„ì¹˜ê°€ ê²°ì •ì ì„.\n![image.png](LM_obs1/image.png)\n- **External Cephalic Version (ECV):** Twinsì—ì„œëŠ” **Absolute Contraindication**. (ìœ„í—˜í•¨: Placental abruption, cord entanglement ë“±).\n- **Vasa Previa:** IVFë‚˜ Twinsì—ì„œ ë¹ˆë„ê°€ ë†’ìŒ. Vesselì´ Internal osë¥¼ ê°€ë¡œì§€ë¦„  â†’ ì–‘ë§‰ íŒŒì—´ ì‹œ íƒœì•„ í˜ˆê´€ì´ ì°¢ì–´ì§  â†’ **Fetal Exsanguination** (ì¦‰ì‹œ C/S í•„ìš”).\n---\n## 4. Section 7: Demise (IUFD - Intrauterine Fetal Demise)\n> \"The Hardest Room to Walk Into\"\n>\n**Diagnosis:**\n- í™˜ìê°€ \"ì´í‹€ ë™ì•ˆ íƒœë™ì´ ì—†ì–´ìš”\"ë¼ê³  í•¨.\n- Dopplerë¡œ ì‹¬ë°•ë™ ì•ˆ ë“¤ë¦¼  â†’ **Real-time Ultrasound**ë¡œ í™•ì§„ (Cardiac activity ì—†ëŠ” ê²ƒ í™•ì¸).\n**Management (The Counter-intuitive Part):**\n- **Scenario:** 34ì£¼ IUFD, ì‚°ëª¨ëŠ” ìŠ¬í¼í•˜ë©° ë‹¹ì¥ ìˆ˜ìˆ (C-section)ì„ ì›í•¨.\n- **Doctor's Decision:** â˜… **Vaginal Delivery (Induction of Labor)**\n    - **Why?** C-sectionì€ ìê¶ì— ì˜êµ¬ì ì¸ í‰í„°(Scar)ë¥¼ ë‚¨ê²¨ ë‹¤ìŒ ì„ì‹  ì‹œ **Uterine Rupture** ìœ„í—˜ì„ ë†’ì„. ì£½ì€ íƒœì•„ë¥¼ ìœ„í•´ ì‚°ëª¨ì˜ ë¯¸ë˜ ìƒì‹ ëŠ¥ë ¥ì„ í¬ìƒí•  ìˆ˜ ì—†ìŒ (Maternal morbidity ìµœì†Œí™”).\n    - **Exceptions for C-section:**\n        1. Prior Classical C-section (Vertical scar).\n        2. Placenta Previa (ì§ˆì‹ ë¶„ë§Œ ë¶ˆê°€ëŠ¥).\n        3. Emergency maternal indication.\n**Risks of Waiting (Retention of Dead Fetus): ì•„ë¬´ê²ƒë„ ì•ˆí•˜ê³  ì§‘ê°€ì„œ ì£½ì€ íƒœì•„ê°€ ì•Œì•„ì„œ ë‚˜ì˜¬ë•Œê¹Œì§€ ê¸°ë‹¤ë¦¬ë©´ ì•ˆë˜ëŠ” ì´ìœ :**\n- **Coagulopathy (DIC):** íƒœì•„ ì¡°ì§ì´ ë¶„í•´ë˜ë©´ì„œ **Thromboplastin**ì´ ëª¨ì²´ í˜ˆì•¡ìœ¼ë¡œ ìœ ì…  â†’ Clotting factors ì†Œëª¨  â†’ Uncontrolled Bleeding.\n- ë”°ë¼ì„œ ë„ˆë¬´ ì˜¤ë˜ ê¸°ë‹¤ë¦¬ì§€ ì•Šê³  **Induction** ê¶Œì¥.\n---\n## 5. Section 8: Hydrops Fetalis\n> \"System-wide Failure\"\n>\n**Definition:**\n- Abnormal fluid accumulation in **2 or more compartments** (Skin edema, Ascites, Pleural effusion, Pericardial effusion).\n- Placentaë„ ë‘êº¼ì›Œì§ (Placentomegaly).\n**Mechanism:**\n- **Severe Anemia**  â†’ Heart tries to compensate (High output)  â†’ **High Output Heart Failure**  â†’ Venous pressure ì¦ê°€  â†’ Fluid leakage (Hydrops).","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-170"}
{"chunk_type":"transcript_chunk","text":"**Causes:**\n1. **Immune:** **Rh Incompatibility** (Mom Rh-, Baby Rh+). ì—„ë§ˆ í•­ì²´ê°€ ì•„ê¸° RBC ê³µê²© (Hemolysis). (RhoGAMìœ¼ë¡œ ì˜ˆë°© ê°€ëŠ¥í•´ì ¸ì„œ ìš”ì¦˜ì€ ë“œë¬¾).\n2. **Non-Immune (Most common now):**\n    - â˜… **Parvovirus B19:** ê³¨ìˆ˜(Bone marrow)ë¥¼ ê°ì—¼ì‹œì¼œ RBC ìƒì‚° ì¤‘ë‹¨  â†’ Severe Anemia.\n    - **Alpha-Thalassemia Major (Hb Barts):** 4ê°œ ìœ ì „ì ëª¨ë‘ ê²°ì† (Deletion). ì‚°ì†Œ ì¹œí™”ë ¥ì´ ë„ˆë¬´ ë†’ì•„ ì¡°ì§ì— ì‚°ì†Œë¥¼ ì•ˆ ì¤Œ  â†’ Fetal suffocation & Heart failure.\n    - Genetic: Turner syndrome(lymphatic destruction), Down syndrome(Heart defects)\n---\n### ğŸ”¥ Rapid Fire Recap\n1. **IUGR + Reverse End-Diastolic Flow**  â†’ **Diagnosis:** Fetal Hypoxia/Suffocation  â†’ **Action:** Immediate Delivery (C-Sec).\n2. **Twins + Twin A is Breech**  â†’ **Diagnosis:** Malpresentation risk  â†’ **Action:** C-Section (No ECV!).\n3. **IUFD (Fetal Death) Diagnosis**  â†’ **Key Tool:** Real-time Ultrasound (NOT just Doppler).\n4. **IUFD Management**  â†’ **Goal:** Protect future uterus  â†’ **Action:** Vaginal Delivery (Induction).\n5. **Hydrops Fetalis**  â†’ **Pathophysiology:** Severe Anemia  â†’ High Output Heart Failure.\n    1. Rh, Parvo B19, ì—¼ìƒ‰ì²´ë¬¸ì œ (Down, turner), Hb Barts (alpha ì§€ì¤‘í•´ì„±ë¹ˆí˜ˆ)\n6. **Parvovirus B19 in Pregnancy**  â†’ **Mechanism:** Attacks Erythroid precursors  â†’ Aplastic Anemia  â†’ Hydrops.\n**Verbatim Dictation (0:00 - 0:30)**\n\"Welcome back to the wards. If you were listening to this, you've likely traded your sleep schedule for a pager and a white coat that's seen better days. Oh for sure. Grab your stethoscope and maybe a double shot of espresso black, no sugar. Because today, we are stepping onto the labor and delivery floor. And we aren't heading to the low risk birthing suites with the dim lighting of the jacuzzis, we are walking straight into the high acuity zone. Yeah. We are doing a deep dive into the absolute bread and butter but also the potential killers of obstetrics.\"\n---\n# Section 9: Hypertensive Disorders of Pregnancy (USMLE Step 2 CK)\nì•ˆë…•í•˜ì„¸ìš”! USMLE Step 2 CK OB/GYN íŒŒíŠ¸ ì¤‘ ê°€ì¥ ì¤‘ìš”í•˜ê³  ìœ„í—˜í•œ **Hypertensive Disorders**ë¥¼ ì •ë¦¬í•´ë“œë¦¬ê² ìŠµë‹ˆë‹¤. ì‹œí—˜ì— ë¬´ì¡°ê±´ ë‚˜ì˜¤ëŠ” High Yield í† í”½ì…ë‹ˆë‹¤. ğŸš‘ğŸ¤°\n## 1. Big Picture & Pathophysiology ğŸ§ \nì´ ì£¼ì œì˜ í•µì‹¬ì€ **\"20-week line in the sand\"**ì…ë‹ˆë‹¤. ì„ì‹  20ì£¼ë¥¼ ê¸°ì¤€ìœ¼ë¡œ ë³‘íƒœìƒë¦¬ì™€ ì§„ë‹¨ì´ ì™„ì „íˆ ê°ˆë¦½ë‹ˆë‹¤.\n### **Mental Model: The Placenta is the Culprit**\nì™œ 20ì£¼ê°€ ì¤‘ìš”í• ê¹Œìš”? ë°”ë¡œ **Placenta Remodeling** ë•Œë¬¸ì…ë‹ˆë‹¤.\n- **Normal Physiology:** Trophoblast cellsê°€ ìê¶ì˜ Spiral arteriesë¥¼ ì¹¨íˆ¬í•˜ì—¬, ì¢ê³  ì €í•­ì´ ë†’ì€ í˜ˆê´€ì„ **Wide, Low-resistance pools**ë¡œ ë¦¬ëª¨ë¸ë§í•©ë‹ˆë‹¤. ì´ ê³¼ì •ì´ ë³´í†µ 20ì£¼ì— ì™„ë£Œë©ë‹ˆë‹¤.\n- **Pathology:** ì´ ë¦¬ëª¨ë¸ë§ì´ ì‹¤íŒ¨í•˜ë©´(shallow invasion), í˜ˆê´€ì´ ì—¬ì „íˆ ë»£ë»£í•˜ê³  ì €í•­ì´ ë†’ìŠµë‹ˆë‹¤(High resistance). ê²°ê³¼ì ìœ¼ë¡œ íƒœë°˜ì— í˜ˆë¥˜ ê³µê¸‰ì´ ë¶€ì¡±í•´ì§€ê³ (Ischemia), \"í™”ê°€ ë‚œ\" íƒœë°˜ì´ ì—„ë§ˆ í˜ˆì•¡ìœ¼ë¡œ **Anti-angiogenic factors**ë¥¼ ë¿œì–´ë‚´ì–´ ì „ì‹ ì ì¸ í˜ˆê´€ ì†ìƒ(Endothelial damage)ì„ ì¼ìœ¼í‚µë‹ˆë‹¤.\n`OBSTETRICS_PATHOLOGY\n â”œâ”€â”€ < 20 Weeks Gestation\n â”‚    â””â”€â”€ Chronic Hypertension (Pre-existing vascular pathology)\n â”‚\n â””â”€â”€ â‰¥ 20 Weeks Gestation (Placental Issue)\n      â”œâ”€â”€ No Proteinuria/End-organ damage\n      â”‚    â””â”€â”€ Gestational Hypertension\n      â”‚                                \n      â””â”€â”€ Proteinuria OR End-organ damage present\n           â”œâ”€â”€ Preeclampsia (Mild)\n           â”œâ”€â”€ Preeclampsia with Severe Features (The Danger Zone ğŸš¨)\n           â”‚    â”œâ”€â”€ BP â‰¥ 160/110\n           â”‚    â”œâ”€â”€ End-organ damage (Liver, Kidney, Lung, Brain)\n           â”‚    â””â”€â”€ HELLP Syndrome\n           â”‚\n           â””â”€â”€ Eclampsia (Seizures âš¡ï¸)`\n---\n## 2. Diagnosis & The Spectrum of Disease ğŸ“Š\ní˜ˆì•• ê¸°ì¤€: **Systolic â‰¥ 140 OR Diastolic â‰¥ 90** (4ì‹œê°„ ê°„ê²© 2íšŒ ì¸¡ì •)\nì ˆëŒ€ í•œ ë²ˆì˜ ì¸¡ì •ìœ¼ë¡œ ì§„ë‹¨í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤ (White coat syndrome ë°°ì œ).","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-190"}
{"chunk_type":"transcript_chunk","text":"### **Classification Table**\n| **Disorder** | **Timing** | **Key Features** | **Proteinuria?** |\n| --- | --- | --- | --- |\n| **Chronic Hypertension** | < 20 Weeks | ì„ì‹  ì „ë¶€í„° ìˆì—ˆê±°ë‚˜ 20ì£¼ ì´ì „ì— ë°œê²¬ë¨. | (-/+) Baselineì¼ ìˆ˜ ìˆìŒ |\n| **Gestational Hypertension** | â‰¥ 20 Weeks | 20ì£¼ ì´í›„ ë°œìƒ, ì¶œì‚° í›„ 12ì£¼ ë‚´ ì •ìƒí™”. | **Negative** |\n| **Preeclampsia** | â‰¥ 20 Weeks | New onset HTN + ë‹¨ë°±ë‡¨ í˜¹ì€ End-organ damage. | **Positive** or End-organ signs |\n| **Superimposed Preeclampsia** | Chronic HTN í™˜ì | ê°‘ì‘ìŠ¤ëŸ¬ìš´ BP ì•…í™”\ní˜¹ì€ ìƒˆë¡œìš´ ë‹¨ë°±ë‡¨/ì¥ê¸° ì†ìƒ ë°œìƒ. | **New/Worsening** |\n| **Eclampsia** | Any | Preeclampsia\n+ **Seizures** (Grand mal). | Yes |\n### Preeclampsia\n- 20ì£¼ì´í›„!\n### **â˜… Preeclampsia with Severe Features Criteria (Must Memorize)**\n> ì§€ê¸ˆ ë‚³ì„ì§€ë§ì§€ ê²°ì •í•˜ëŠ” ê¸°ì¤€ì´ë¼ ì™¸ì›Œì•¼ë¨.\n>\në‹¨ìˆœ Preeclampsiaì™€ ë‹¬ë¦¬ ì¦‰ê°ì ì¸ ì²˜ì¹˜ê°€ í•„ìš”í•©ë‹ˆë‹¤. ë‹¤ìŒ ì¤‘ í•˜ë‚˜ë¼ë„ ìˆìœ¼ë©´ í•´ë‹¹ë©ë‹ˆë‹¤. â†’ induction or c-sec\n> - vasoconstriction, í˜ˆê´€ì†ìƒ\n  BP â†‘ \n  thrombocytopenia (ì—¬ëŸ¬êµ°ë°ì„œ microthrombi â†’ í˜ˆì „ë§Œë“¤ì–´ì§)\n- ìœ íš¨í˜ˆë¥˜ëŸ‰ ê°ì†Œ / ì´ìƒí•œë° í”¼ê°€ ë§ë‹¤.\n  AKI\n- permeability â†‘\n- albuin loss â†’ ìŠ¤í€ì§€ê°€ ì—†ìŒ â†’ ë‹¤ë¥¸ë°ê°€ ë¶€ìŒ\n  ë‡Œë¶€ì¢… (ì‹œì•¼ì´ìƒ, ë°œì‘)\n  ê°„ë¶€ì „\n> \n- **Blood Pressure:** SBP â‰¥ 160 or DBP â‰¥ 110 (Stroke risk!)\n- **Platelets:** < 100,000 (Thrombocytopenia) (microvascular consumption, thrombus everywhere)\n- **Liver:** LFTs 2x Upper Limit, Severe RUQ/Epigastric pain (Glisson's capsule stretching)\n- **Kidney:** Cr > 1.1 or doubling of baseline (Renal insufficiency)\n- **Lungs:** Pulmonary Edema (Flash edema) (Albumin drops. í”¼ì•ˆì— ìŠ¤í€ì§€ ì—†ìŒ. â†’ í, ì‹ ì¥ë¶€ì „)\n- **Brain:** New onset headache unresponsive to meds, visual disturbances. (ë‡Œë¶€ì¢…)\n### Eclampsia\n- seizure\n- baby decel:\n- management:\n    1. magnesium\n    2. stable the mother (airway, ì™¼ìª½ìœ¼ë¡œ ëŒë ¤ì„œ í˜ˆë¥˜ëŸ‰ ê°œì„ )\n    3. â˜… DELIVERY\n        \n        note: active ë°œì‘ ì¤‘ì—ëŠ” c-secí•˜ì§€ ì•ŠìŒ. stabilize â†’ deliver\n---\n## 3. Management & Pharmacology ğŸ’Š\në‘ ëª…ì˜ í™˜ì(Mom & Baby)ë¥¼ ë™ì‹œì— ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤.\n### **Anti-hypertensives (Maternal Safety)**\níƒœë°˜ í˜ˆë¥˜ë¥¼ ìœ ì§€í•˜ë©´ì„œ ì—„ë§ˆì˜ ë‡Œì¶œí˜ˆì„ ë§‰ì•„ì•¼ í•©ë‹ˆë‹¤.\n- **Methyldopa (The Grandma):** Alpha-2 agonist. ì•„ì£¼ ì•ˆì „í•˜ì§€ë§Œ ì•½íš¨ê°€ ì•½í•¨.\n- **Labetalol (The Workhorse):** Alpha/Beta blocker. íƒœë°˜ í˜ˆë¥˜ ìœ ì§€ì— ì¢‹ìŒ. **ì²œì‹(Asthma)ì´ë‚˜ ì„œë§¥(Bradycardia)** í™˜ìì—ì„œëŠ” í”¼í•  ê²ƒ. IV ê¸‰ì„±ê¸°ì‚¬ìš©.\n- **Hydralazine:** Direct vasodilator. ê¸‰ì„±ê¸° ì¡°ì ˆì— ì‚¬ìš© (IV).\n- **Nifedipine:** Calcium Channel Blocker (Oral). ì‘ê¸‰ ì‹œë‚˜ ìœ ì§€ ìš”ë²• ì‚¬ìš©.\n> One Line Vibe: \"Methyldopa, Labetalol, Hydralazine, Nifedipine â†’ These are your 4 best friends.\"\n>","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-210"}
{"chunk_type":"transcript_chunk","text":"- **ACEi, ARBsëŠ” ì ˆëŒ€ ê¸ˆê¸°** (Renal dysgenesis, Oligohydramnios ìœ ë°œ).\n- ì´ë‡¨ì œ ê¸ˆì§€: puffyí•´ë³´ì—¬ë„ dry inside (â†“ intravascular volume)\n### **Seizure Prophylaxis: Magnesium Sulfate (MgSo4)** âš¡ï¸\n- **ëª©ì :** í˜ˆì•• ì¡°ì ˆìš©ì´ ì•„ë‹˜! ì˜¤ì§ **Seizure ì˜ˆë°©(Neuroprotection)** ëª©ì .\n- **Mechanism:** Neuronal membrane stabilizing.\n- **Toxicity Signs (ìˆœì„œëŒ€ë¡œ ì§„í–‰):**\n    1. Loss of Deep Tendon Reflexes (DTRs) - **First sign!** â˜…\n    2. Respiratory Depression\n    3. Cardiac Arrest\n- **Antidote:** **Calcium Gluconate** (Keep it taped to the wall!).\n- **Contraindication:** Myasthenia Gravis, Renal failure (Magnesiumì€ ì‹ ì¥ìœ¼ë¡œ ë°°ì„¤ë¨ â†’ ì‹ ë¶€ì „ ì‹œ ë…ì„± ìœ„í—˜ ê¸‰ì¦).\n### **Fluid Management**\nPreeclampsia í™˜ìëŠ” í˜ˆê´€ íˆ¬ê³¼ì„±ì´ ë†’ì•„ì ¸ ìˆìŠµë‹ˆë‹¤(Leaky vessels). **Intravascularly dry**í•˜ì§€ë§Œ **Extravascularly wet** (Edema) ìƒíƒœì…ë‹ˆë‹¤. Diuretics(Furosemide)ëŠ” íë¶€ì¢…(Pulmonary edema)ì´ ì˜¨ ê²½ìš°ì—ë§Œ ì œí•œì ìœ¼ë¡œ ì‚¬ìš©í•©ë‹ˆë‹¤.\n---\n## 4. Specific Clinical Entities ğŸ”¥\n### **HELLP Syndrome**\nPreeclampsiaì˜ ì‹¬ê°í•œ ë³€í˜•\n> ì‚°ëª¨ê°€ ì˜¤ë¥¸ìª½ ë°°ë¥¼ ì¥ì–´ì§œê³ . ì•„íŒŒë³´ì´ê³ . í™©ë‹¬ì´ ìˆìŒ.\nâ†’ ddx. cholestasis, gallstone, hepatitis, HELLP\n> \n- **H**emolysis (Schistocytes, Bilirubin â†‘) (microangiopathic hemolytic anemia)\n- **E**levated **L**iver enzymes\n- **L**ow **P**latelets\n- ì¹˜ë£Œ: **Immediate Delivery** (ì•ˆì •ì„ ì·¨í•œë‹¤ê³  ë‚˜ì•„ì§€ì§€ ì•ŠìŒ).\n### **Differential: Acute Fatty Liver of Pregnancy (AFLP) vs HELLP**\nHELLPì™€ ë¹„ìŠ·í•´ ë³´ì´ì§€ë§Œ ë‹¤ë¦…ë‹ˆë‹¤. ê°„ë¶€ì „(Liver failure) ì§•í›„ë¥¼ ì°¾ìœ¼ì„¸ìš”.\n> í™©ë‹¬ìˆê³  ë°°ì•„í”„ê³  ì•„íŒŒë³´ì´ëŠ” ì‚°ëª¨ê°€ ì˜´.\n> \n- HELLPì™€ì˜ ê°ë³„ â˜…\n- hypertension ì—†ìŒ. platelet ì •ìƒì¸ë° PT/INR ìƒìŠ¹\n- **Key Features:** LIVER FAILURE\n    - â˜… Hypoglycemia (ì €í˜ˆë‹¹)\n    - â˜… Coagulopathy (PT/INR ì—°ì¥) / DIC\n        - HELLPëŠ” DICê°€ ë‚˜íƒ€ë‚˜ë„ ë‚˜ì¤‘ì— ë‚˜íƒ€ë‚¨.\n        - AFLPëŠ” ì‘ê³ ì¸ìê°€ ì‚¬ë¼ì ¸ì„œ DICê°€ ê¸ˆë°© ë‚˜íƒ€ë‚¨. IV bleeding.\n    - Ammonia ìƒìŠ¹.\n- **Comparison:** HELLPëŠ” í˜ˆì†ŒíŒ ê°ì†Œì™€ ìš©í˜ˆì´ ë©”ì¸ì´ì§€ë§Œ, AFLPëŠ” \"ê°„ì´ ì¼ì„ ì•ˆ í•˜ëŠ”(Synthetic function failure)\" ìƒíƒœì…ë‹ˆë‹¤. ì €í˜ˆë‹¹ì´ ìˆìœ¼ë©´ AFLPë¥¼ ê°•ë ¥ ì˜ì‹¬!\n---","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-230"}
{"chunk_type":"recap_summary","text":"## 5. Rapid Fire Recap: Clinical Scenarios (Section 9.5) ğŸš€\nì˜¤ë””ì˜¤ ë§ˆì§€ë§‰ì— ë‚˜ì˜¨ 5ê°€ì§€ ì‹œë‚˜ë¦¬ì˜¤ ì •ë¦¬ì…ë‹ˆë‹¤. ì‹œí—˜ì¥ì—ì„œ ë°”ë¡œ ë– ì˜¬ë¦¬ì„¸ìš”!\n**Scenario 1: Early Onset HTN**\n- **Situation:** 12ì£¼ ì„ì‚°ë¶€, BP 150/90. ì†Œë³€ ê¹¨ë—í•¨.\n- **Diagnosis:** **Chronic Hypertension** (20ì£¼ ì´ì „).\n- **Action:** Monitor, treat if severe.\n**Scenario 2: The Crash Section**\n- **Situation:** 38ì£¼, BP 160/110, ë‘í†µ(Headache), ë‹¨ë°±ë‡¨ 3+.\n- **Diagnosis:** **Preeclampsia with Severe Features**.\n- **Action:** **Stabilize & Deliver**. (IV Magnesium Sulfate + IV Antihypertensives + Delivery).\n**Scenario 3: The Toxic Patient**\n- **Situation:** Mag drops ë‹¬ê³  ìˆëŠ” í™˜ì. DTR ì†Œì‹¤(Reflexes absent), í˜¸í¡ìˆ˜ ê°ì†Œ.\n- **Diagnosis:** **Magnesium Toxicity**.\n- **Action:** Stop Mag â†’ Give **Calcium Gluconate**.\n**Scenario 4: The Mimic**\n- **Situation:** 36ì£¼, RUQ pain, BP ë†’ìŒ, Platelet 60k, Glucose 95 (ì •ìƒ).\n- **Diagnosis:** **HELLP Syndrome**.\n- **Action:** Delivery.","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-245"}
{"chunk_type":"transcript_chunk","text":"**Scenario 5: The Liver Failure**\n- **Situation:** 36ì£¼, Nausea/Vomiting, Jaundice, Glucose 40 (Hypoglycemia!), High INR.\n- **Diagnosis:** **Acute Fatty Liver of Pregnancy (AFLP)**.\n- **Action:** Emergency Delivery + Glucose support.\n---\n**Next Step for You:**\nChronic HTN í™˜ìì—ì„œ superimposed preeclampsiaë¥¼ ê°ë³„í•˜ëŠ” ê²ƒì´ ê½¤ ê¹Œë‹¤ë¡œìš¸ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì´ì™€ ê´€ë ¨ëœ **\"Superimposed Preeclampsia ì§„ë‹¨ ê¸°ì¤€ê³¼ Baseline w/u\"**ì— ëŒ€í•´ ë” ìì„¸íˆ ì •ë¦¬í•´ ë“œë¦´ê¹Œìš”?","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-255"}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ Rapid Fire Recap: Must-Know High Yields\nStep 2 CK ì‹œí—˜ ì§ì „ í™•ì¸í•  í•µì‹¬ ìš”ì•½ì…ë‹ˆë‹¤.\n| **Clinical Scenario** | **Likely Physiology / Diagnosis** | **Key Action / Concept** |\n| --- | --- | --- |\n| **Pregnant, Cr 1.0 mg/dL** | **Pathologic** (Renal Insufficiency) | ì„ì‹  ì¤‘ ì •ìƒ Crì€ 0.4~0.8ì„. 1.0ì€ ë¹„ì •ìƒ. |\n| **Right Flank Pain, Mild Hydro** | **Physiologic Hydronephrosis** | Progesterone + Uterus ì••ë°•. reassurance (if no infection). |\n| **Back Pain, Waddling** | **Lordosis** (Hyper-lordosis) | MRI ê¸ˆì§€. Conservative management (Reassurance). |\n| **Trauma, Rh- Mom** | **Fetomaternal Hemorrhage** | **Kleihauer-Betke Test**ë¡œ ì¶œí˜ˆëŸ‰ í™•ì¸ í›„ RhoGAM ìš©ëŸ‰ ê²°ì •. |\n| **Induction â†’ Seizure/Confusion** | **Water Intoxication** | Oxytocinì´ **ADH**ì™€ êµì°¨ ë°˜ì‘í•˜ì—¬ Hyponatremia ìœ ë°œ. |\n| **Low Amniotic Fluid** | **Oligohydramnios** | ì›ì¸: Renal issue / Placental insufficiency. ê²°ê³¼: **Cord Compression** (Variable Decels). |\n**Verbatim Dictation (0:00 ~ 0:30)**\n\"Welcome back to the wards. Go ahead and drop your bag in the team room, maybe grab a coffee. We're getting right to work. Yep, time to prep. And today we're tackling an absolute monster of a topic. We are. We're opening up the Fetus section of the study stack for this deep dive. Our mission today is mastering the clinical logic behind sections 3.0 through 3.4. We're talking Gestational Age, Fetal Surveillance... The heart rate patterns that give everyone anxiety. And of course the absolute alphabet soup of prenatal testing.\"\n---\n# ğŸ“ **The Wards: Fetus Section (3.0 - 3.4) Study Stack**\n## 1. Introduction: The Fetus\nUSMLE Step 2 ì¤€ë¹„ë¥¼ ìœ„í•œ **Fetus Section (Section 3.0~3.4)** ê°•ì˜ë¡ì…ë‹ˆë‹¤.\nì„ìƒì ìœ¼ë¡œ ê°€ì¥ ê¸°ì´ˆê°€ ë˜ëŠ” **Gestational Age(ì¬íƒœì£¼ìˆ˜)**ë¶€í„°, ëª¨ë‘ë¥¼ ë¶ˆì•ˆí•˜ê²Œ ë§Œë“œëŠ” **Fetal Heart Rate Pattern**, ê·¸ë¦¬ê³  ë³µì¡í•œ **Prenatal Testing**ê¹Œì§€ ë‹¤ë£¹ë‹ˆë‹¤. ë‹¨ìˆœíˆ ì•”ê¸°í•˜ëŠ” ê²ƒì´ ì•„ë‹ˆë¼, *Clinical Logic*ì„ ì´í•´í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-37"}
{"chunk_type":"recap_quiz_seed","text":"# ğŸ”¥ Rapid Fire Recap\nê°•ì˜ì—ì„œ ë‹¤ë£¬ í•µì‹¬ ë‚´ìš©ì„ ë¹ ë¥´ê²Œ ì •ë¦¬í•©ë‹ˆë‹¤.\n1. **Dating Dilemma**\n    - **Scenario:** LMP vs Ultrasound ë‚ ì§œ ë¶ˆì¼ì¹˜ (íŠ¹íˆ 1ë¶„ê¸°).\n    - **Action:** â˜… **Trust the Ultrasound (CRL)**. Due dateëŠ” í•œ ë²ˆ ì •í•´ì§€ë©´ ë°”ë€Œì§€ ì•ŠìŒ.\n2. **Fetal Surveillance**\n    - **Scenario:** \"Baby isn't moving\" (Decreased fetal movement).\n    - **Action:** **NST** ë¨¼ì € ì‹œí–‰.\n    - **Result:** Non-reactive (No accelerations).\n    - **Next Step:** Vibroacoustic stimulation (Wake up baby) â†’ ê·¸ë˜ë„ ì•ˆ ë˜ë©´ **BPP**.\n    - **BPP Score:** 4ì  ì´í•˜ëŠ” **Immediate Delivery**.\n3. **Intrapartum Decelerations (VEAL CHOP)**\n    - **Variable Decels** â†’ **Cord Compression** â†’ **Reposition Mom**.\n    - **Late Decels** â†’ **Placental Insufficiency** â†’ **Intrauterine Resuscitation** (O2, IV, Stop Pitocin) â†’ Failì‹œ C-Section.\n    - **Sinusoidal** â†’ **Severe Fetal Anemia** â†’ Emergency.\n4. **Prenatal Genetic Screening**\n    - **Fact:** **NIPT** (Cell-free DNA)ëŠ” ì •í™•í•˜ì§€ë§Œ **Screening**ì´ë‹¤. í™•ì§„ì„ ìœ„í•´ì„œëŠ” **CVS**ë‚˜ **Amnio**ê°€ í•„ìš”í•˜ë‹¤.\n    - **Down Syndrome Pattern (Quad):** **HI**gh levels of **H**CG & **I**nhibin A.\n**Verbatim Dictation (0:00 ~ 0:30)**\n\"Welcome back. Today we're digging into a topic that's, well, it's absolutely critical in obstetrics. It really is. We're talking about congenital infections and screening. This is where, you know, maternal health and fetal outcomes collide and the margin for error is just so thin. Exactly. We're focusing on sections 4 through 4.6 of the material today. This is the bread and butter for the boards but it's also... I mean it's all about pattern recognition for real world practice. Pattern recognition, I like that. Yeah. You have to know who to screen, when to screen, and most importantly, how to stop that vertical transmission dead in its tracks.\"\n---\n# ğŸ“š USMLE Step 2 CK: Congenital Infections & Screening (Section 4 - 4.6)\nì•ˆë…•í•˜ì„¸ìš”! USMLE Step 2 ì¤€ë¹„í•˜ì‹œëŠë¼ ê³ ìƒ ë§ìœ¼ì‹­ë‹ˆë‹¤. ì—…ë¡œë“œí•´ì£¼ì‹  ì˜¤ë””ì˜¤ íŒŒì¼ì€ **Prenatal Screeningê³¼ Congenital Infections**ì— ëŒ€í•œ í•µì‹¬ ë‚´ìš©, íŠ¹íˆ **Vertical Transmission(ìˆ˜ì§ ê°ì—¼)**ì„ ë§‰ê¸° ìœ„í•œ Timingê³¼ Managementë¥¼ ë‹¤ë£¨ê³  ìˆìŠµë‹ˆë‹¤.\nìš”ì²­í•˜ì‹  ëŒ€ë¡œ **Top-down Classification (Structure)**ì„ ë¨¼ì € ë³´ì—¬ë“œë¦¬ê³ , ê° ì„¹ì…˜ë³„ í•µì‹¬ ë‚´ìš©ì„ ì •ë¦¬í•´ ë“œë¦´ê²Œìš”.\n## ğŸŒ³ Big Picture: Prenatal Screening Logic Tree","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-80"}
{"chunk_type":"recap_quiz_seed","text":"## 5. Rapid Fire Recap: Clinical Scenarios (Section 9.5) ğŸš€\nì˜¤ë””ì˜¤ ë§ˆì§€ë§‰ì— ë‚˜ì˜¨ 5ê°€ì§€ ì‹œë‚˜ë¦¬ì˜¤ ì •ë¦¬ì…ë‹ˆë‹¤. ì‹œí—˜ì¥ì—ì„œ ë°”ë¡œ ë– ì˜¬ë¦¬ì„¸ìš”!\n**Scenario 1: Early Onset HTN**\n- **Situation:** 12ì£¼ ì„ì‚°ë¶€, BP 150/90. ì†Œë³€ ê¹¨ë—í•¨.\n- **Diagnosis:** **Chronic Hypertension** (20ì£¼ ì´ì „).\n- **Action:** Monitor, treat if severe.\n**Scenario 2: The Crash Section**\n- **Situation:** 38ì£¼, BP 160/110, ë‘í†µ(Headache), ë‹¨ë°±ë‡¨ 3+.\n- **Diagnosis:** **Preeclampsia with Severe Features**.\n- **Action:** **Stabilize & Deliver**. (IV Magnesium Sulfate + IV Antihypertensives + Delivery).\n**Scenario 3: The Toxic Patient**\n- **Situation:** Mag drops ë‹¬ê³  ìˆëŠ” í™˜ì. DTR ì†Œì‹¤(Reflexes absent), í˜¸í¡ìˆ˜ ê°ì†Œ.\n- **Diagnosis:** **Magnesium Toxicity**.\n- **Action:** Stop Mag â†’ Give **Calcium Gluconate**.\n**Scenario 4: The Mimic**\n- **Situation:** 36ì£¼, RUQ pain, BP ë†’ìŒ, Platelet 60k, Glucose 95 (ì •ìƒ).\n- **Diagnosis:** **HELLP Syndrome**.\n- **Action:** Delivery.","subject":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","page_title":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","episode":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","section_path":["LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12"],"source_doc_id":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12","source_page":null,"source_anchor":"LM_obs1 2f646f2986ee80d3a4e8c9b5ab8a0b12-245"}